BBNX vs TNDM Stock Comparison
TNDM currently leads BBNX in this stock comparison, with AIQ scores of 55 vs 54. The clearest difference is value, while BBNX has the stronger momentum profile.
What is the main difference between BBNX and TNDM?
TNDM leads the current stock comparison as Tandem Diabetes Care, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Beta Bionics, Inc. vs Tandem Diabetes Care, Inc.
TNDM leads
TNDM leads by 1 AIQ points, primarily on Value, having only recently taken the lead back from BBNX. Wall Street currently favors BBNX on target upside.
Fragile: 3 of 6 evidence groups support TNDM, the lead recently changed hands, and its current signal state is conflicted.
Beta Bionics, Inc.
Tandem Diabetes Care, Inc.
The Algovestiq AIQ Score currently favors TNDM over BBNX, 55 versus 54 as of Nov 18, 2026. TNDM's advantage is driven primarily by stronger value, while BBNX holds the stronger momentum profile. TNDM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BBNX. 3 of 6 covered evidence groups favor TNDM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. TNDM lead: Reversed — BBNX led by 5 AIQ points 30 sessions ago; TNDM now leads by 1.
Compare Beta Bionics, Inc. and Tandem Diabetes Care, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare BBNX and TNDM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value39 vs 64TNDM +25
- Momentum72 vs 59BBNX +13
- Quality53 vs 51Even
- Risk Resilience36 vs 38Even
3 of 6 evidence groups favor TNDM. TNDM’s edge is concentrated in value; BBNX keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- Price Reclaimed 200-Day MA — bullish, trend, long horizon
- Accumulation Pattern — bullish, volume, medium horizon (1.61x)
- MACD Bullish Crossover — bullish, momentum, short horizon
TNDM's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BBNX and TNDM both carry a full feed there.
The central trade-off
TNDM (Tandem Diabetes Care, Inc.): the stronger current systematic profile, led by value.
BBNX (Beta Bionics, Inc.): the counter-case, on momentum, analyst expectations — but at materially higher volatility, 109.6% against 87.7%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TNDMTNDM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
TNDMTNDM on combined revenue and EPS growth.
Value
TNDMTNDM on the peer-relative Value factor, by 25 points.
Momentum
BBNXBBNX on the Momentum factor, by 13 points.
Lower downside
TNDMTNDM carries the lower 1-month annualized volatility.
Analyst upside
BBNXBBNX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors TNDM, analyst targets favor BBNX. That disagreement is the most useful thing on this page.
| Measure | BBNX | TNDM | Note |
|---|---|---|---|
| Implied upside to target | +71.7% | +11.4% | BBNX has more room |
| Target dispersion | +56.9% | +10.5% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 15 | 25 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor TNDM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 54 vs 55 |
| Fundamentals | TNDMon balance | revenue growth 10.9% vs 11.4%; EPS growth 1.9% vs 67.7%; TTM ROE -6.1% vs -5.2%; gross margin 58.6% vs 56.6%; operating margin -72.7% vs -2.4% — TNDM takes 4 of 5 decided legs, not all of them |
| Valuation | TNDM | Value 39 vs 64 |
| Technicals | TNDM | Price vs 50-day -22.4% vs -2%; vs 200-day 10.8% vs 6.5% |
| Risk Resilience | Even | Risk Resilience 36 vs 38 |
| Analyst expectations | BBNX | Target upside 71.7% vs 11.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BBNX and TNDM and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TNDM.
How the comparison changed
120 daily snapshots · Jun 1 – Nov 18TNDM lead: Reversed — BBNX led by 5 AIQ points 30 sessions ago; TNDM now leads by 1.
- Today
- TNDM +1
- 54 vs 55
- 7 sessions ago
- Level
- 55 vs 55
- 30 sessions ago
- BBNX +5
- 56 vs 51
- 90 sessions ago
- TNDM +2
- 57 vs 59
The lead changed hands 4 times in this window, most recently on Nov 13 when TNDM moved ahead of BBNX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 1 bearish / 2 neutral, conflicted
Only BBNX
- Golden Cross Active — bullish, trend, long horizon (24.67%)
- Beta Spike Warning — bearish, risk_regime, long horizon
6 bullish / 1 bearish / 2 neutral, conflicted
Only TNDM
- Death Cross Active — bearish, trend, long horizon (8.27%)
- Price Reclaimed 200-Day MA — bullish, trend, long horizon
- Accumulation Pattern — bullish, volume, medium horizon (1.61x)
- MACD Bullish Crossover — bullish, momentum, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Midline Reclaim — bullish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
Both carry 2 more signals that do not separate them: ADX Trend Weakening, ATR Expansion - Breakout Mode.
TNDM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.65%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.06%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BBNX closes the Value gap — currently 25 points behind, the largest single contributor to TNDM's edge.
- 2BBNX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3TNDM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
TNDM leads on balance| Metric | BBNX | TNDM |
|---|---|---|
| Revenue growth (YoY) | 10.9% | 11.4% |
| EPS growth (YoY) | 1.9% | 67.7% |
| Gross margin | 58.6% | 56.6% |
| Operating margin | -72.7% | -2.4% |
| Return on equity (TTM) | -6.1% | -5.2% |
| Debt to equity | 0.02 | 5.45 |
Performance
TNDM leads 4 of 6 windows| Metric | BBNX | TNDM |
|---|---|---|
| 1 week (5 sessions) | 4.6% | 18.7% |
| 1 month (20 sessions) | 0.4% | 23.6% |
| 3 months (63 sessions) | -6.5% | -9.8% |
| 6 months (126 sessions) | 73.6% | 56.6% |
| Year to date | -46.1% | -8.7% |
| 1 year (252 sessions) | -41.7% | 11.1% |
Technicals
TNDM has the stronger structure| Metric | BBNX | TNDM |
|---|---|---|
| RSI (14) | 45.5 | 59.7 |
| ADX (14) | 13 | 16.5 |
| Price vs 50-day | -22.4% | -2% |
| Price vs 200-day | 10.8% | 6.5% |
| Volatility (1M, annualized) | 109.6% | 87.7% |
Risk
Split| Metric | BBNX | TNDM |
|---|---|---|
| Beta | 1.47 | 1.07 |
| Sharpe ratio | -0.16 | 0.49 |
| Sortino ratio | -0.22 | 0.83 |
| Max drawdown | -72.3% | -54.6% |
| Current drawdown | -48.7% | -29% |
| Annualized volatility | 84.7% | 75.7% |
| Value at risk (95%) | -7.4% | -6.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BBNX or TNDM?
On the Algovestiq AIQ Score, TNDM is the stronger of the two as of Nov 18, 2026, scoring 55 against BBNX's 54. The edge comes from value. BBNX is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BBNX or TNDM the better buy right now?
TNDM carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor TNDM over BBNX?
The composite weights Quality, Value, Momentum and Risk Resilience. TNDM leads Value by 25 points; BBNX leads Momentum by 13 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BBNX or TNDM?
Analyst price targets imply +71.7% upside for BBNX and +11.4% for TNDM, so the Street currently favors BBNX. That points the opposite way to the AIQ Score, which favors TNDM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BBNX or TNDM?
TNDM is the better-valued of the two on the peer-relative Value factor. TNDM on the peer-relative Value factor, by 25 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BBNX or TNDM?
TNDM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BBNX or TNDM?
BBNX on the Momentum factor, by 13 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BBNX or TNDM?
TNDM is the more resilient of the two, so the other name carries the higher downside risk. TNDM carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BBNX more profitable than TNDM?
The profitability evidence is mixed: gross margin 58.6% vs 56.6%; operating margin -72.7% vs -2.4%; ttm roe -6.1% vs -5.2%. BBNX leads on one measure and TNDM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is TNDM's lead over BBNX getting stronger or weaker?
TNDM lead: Reversed — BBNX led by 5 AIQ points 30 sessions ago; TNDM now leads by 1. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands 4 times in that window, most recently on 2026-11-13, when TNDM moved ahead of BBNX.
What would change the BBNX vs TNDM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BBNX closes the Value gap — currently 25 points behind, the largest single contributor to TNDM's edge; BBNX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; TNDM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about BBNX and TNDM?
BBNX: 1 bullish / 1 bearish / 2 neutral, conflicted. TNDM: 6 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BBNX is Golden Cross Active (bullish, long horizon). On TNDM it is Death Cross Active (bearish, long horizon).
Compare BBNX and TNDM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.